isoarecolone has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies
| Studies (isoarecolone) | Trials (isoarecolone) | Recent Studies (post-2010) (isoarecolone) | Studies (3,4-dihydroxyphenylacetic acid) | Trials (3,4-dihydroxyphenylacetic acid) | Recent Studies (post-2010) (3,4-dihydroxyphenylacetic acid) |
|---|---|---|---|---|---|
| 7 | 0 | 1 | 5,410 | 38 | 591 |
| Protein | Taxonomy | isoarecolone (IC50) | 3,4-dihydroxyphenylacetic acid (IC50) |
|---|---|---|---|
| intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | 4.17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mirza, NR; Pei, Q; Stolerman, IP; Zetterström, TS | 1 |
1 other study(ies) available for isoarecolone and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
The nicotinic receptor agonists (-)-nicotine and isoarecolone differ in their effects on dopamine release in the nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Arecoline; Dopamine; Male; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Time Factors | 1996 |